Back to search
FDAFDA · Food and drugs·Recall number D-0218-2024

DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in 6000mL bags, Rx only, Fresenius Medical Care NA Waltham, MA 02451, NDC 49230-206-62.

Published January 10, 2024 · Recall initiated: December 28, 2023

Summary

FDA records drug Class II recall D-0218-2024, published January 10, 2024 and initiated December 28, 2023. Recalling firm: Fresenius Medical Care Holdings, Inc.; Status: Ongoing; Reported quantity: 69,590 bags; Lot: Part Number: 077-60621, Lot #: 23JK02010, Exp. Date 1/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Holdings, Inc.
Distributor
Nationwide within the United States
Lot
Part Number: 077-60621, Lot #: 23JK02010, Exp. Date 1/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in 6000mL bags, Rx only, Fresenius Medical Care NA Waltham, MA 02451, NDC 49230-206-62. recalled?

Yes. FDA published recall D-0218-2024 on January 10, 2024. Reported hazard: Lack of Sterility Assurance

What should I do if I have this product?

Voluntary: Firm initiated · Letter